APA引文

Barlas, S. (2015). FDA Considers More Rigorous Enforcement For Homeopathic Products Over Safety Risks: New Labeling Is Possible; Pre-Market Testing Seems Unlikely. P T.

Citação norma Chicago

Barlas, Stephen. "FDA Considers More Rigorous Enforcement For Homeopathic Products Over Safety Risks: New Labeling Is Possible; Pre-Market Testing Seems Unlikely." P T 2015.

MLA引文

Barlas, Stephen. "FDA Considers More Rigorous Enforcement For Homeopathic Products Over Safety Risks: New Labeling Is Possible; Pre-Market Testing Seems Unlikely." P T 2015.

警告：這些引文格式不一定是100％准確.